ORCHARD THERAPEUTICS NORTH AMERICA

Lobbying client · Massachusetts · filed 2025 to 2026

Health

$150,000 Reported spend

7 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 7 filings. Everything on this page is grouped by the client's LDA id (65681), not by name.

Firms hired 1

CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS $150,000 7 filings

Reported by year 2 years

2026 $60,000 2 filings
2025 $90,000 5 filings

Issues lobbied 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 6

Health & Human Services, Dept of (HHS) 5
HOUSE OF REPRESENTATIVES 5
SENATE 5
Executive Office of the President (EOP) 3
Centers For Medicare and Medicaid Services (CMS) 2
Food & Drug Administration (FDA) 2

Recent filings 7 total

Q2

CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $30,000 income · posted Jul 16, 2026

View → Q1

CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $30,000 income · posted Apr 20, 2026

View → Q4

CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $30,000 income · posted Jan 16, 2026

View → Q3

CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $30,000 income · posted Oct 17, 2025

View → RA

CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS

3rd Quarter (July 1 - Sep 30) 2025 · posted Sep 19, 2025

View → Q2

CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $30,000 income · posted Jul 21, 2025

View → RR

CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS

2nd Quarter (Apr 1 - June 30) 2025 · posted Apr 11, 2025

View →

Foreign entities disclosed 3

KYOWA KIRIN INTERNATIONAL PLC United Kingdom named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0
ORCHARD THERAPEUTICS (EUROPE) LIMITED United Kingdom named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $90,000
ORCHARD THERAPEUTICS LIMITED United Kingdom named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.